Growth Metrics

Health Catalyst (HCAT) Cost of Revenue (2018 - 2026)

Health Catalyst filings provide 9 years of Cost of Revenue readings, the most recent being $35.3 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 18.26% to $35.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $98.2 million, a 42.42% decrease, with the full-year FY2025 number at $159.5 million, down 3.83% from a year prior.
  • Cost of Revenue hit $35.3 million in Q1 2026 for Health Catalyst, roughly flat from $35.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $114.1 million in Q4 2023 to a low of $12.7 million in Q2 2024.
  • Median Cost of Revenue over the past 5 years was $35.3 million (2026), compared with a mean of $37.7 million.
  • Biggest five-year swings in Cost of Revenue: surged 124.07% in 2022 and later crashed 66.06% in 2025.
  • Health Catalyst's Cost of Revenue stood at $75.9 million in 2022, then surged by 50.25% to $114.1 million in 2023, then tumbled by 36.67% to $72.2 million in 2024, then crashed by 51.13% to $35.3 million in 2025, then fell by 0.01% to $35.3 million in 2026.
  • The last three reported values for Cost of Revenue were $35.3 million (Q1 2026), $35.3 million (Q4 2025), and $14.4 million (Q3 2025) per Business Quant data.